Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
148.95
+5.18 (3.60%)
At close: Feb 27, 2026, 4:00 PM EST
148.74
-0.21 (-0.14%)
After-hours: Feb 27, 2026, 7:57 PM EST
Gilead Sciences Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 143.5, with a low estimate of 112 and a high estimate of 177. The average target predicts a decrease of -3.66% from the current stock price of 148.95.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Gilead Sciences stock from 18 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 7 | 7 | 8 | 7 |
| Buy | 12 | 10 | 10 | 9 | 9 | 8 |
| Hold | 6 | 6 | 5 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 23 | 22 | 22 | 20 | 21 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $170 | Strong Buy | Reiterates | $170 | +14.13% | Feb 23, 2026 |
| Barclays | Barclays | Hold Initiates $155 | Hold | Initiates | $155 | +4.06% | Feb 20, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $103 → $118 | Hold | Maintains | $103 → $118 | -20.78% | Feb 11, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $145 → $152 | Strong Buy | Maintains | $145 → $152 | +2.05% | Feb 11, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $150 → $165 | Buy | Maintains | $150 → $165 | +10.78% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
30.82B
from 29.44B
Increased by 4.68%
Revenue Next Year
32.61B
from 30.82B
Increased by 5.81%
EPS This Year
8.92
from 6.78
Increased by 31.56%
EPS Next Year
9.62
from 8.92
Increased by 7.84%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 32.4B | 35.5B | |||
| Avg | 30.8B | 32.6B | |||
| Low | 29.1B | 30.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.0% | 15.3% | |||
| Avg | 4.7% | 5.8% | |||
| Low | -1.0% | -2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 9.98 | 11.75 | |||
| Avg | 8.92 | 9.62 | |||
| Low | 6.25 | 6.81 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 47.1% | 31.7% | |||
| Avg | 31.6% | 7.8% | |||
| Low | -7.8% | -23.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.